Free Trial

Medical Properties Trust (MPW) Stock Forecast & Price Target

$5.11
+0.14 (+2.82%)
(As of 07/24/2024 ET)

Medical Properties Trust - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 13 Wall Street analysts who have issued ratings for Medical Properties Trust in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 13 analysts, 4 have given a sell rating, 8 have given a hold rating, and 1 has given a buy rating for MPW.

Consensus Price Target

$5.61
9.86% Upside
High Forecast$10.00
Average Forecast$5.61
Low Forecast$4.00

According to the 13 analysts' twelve-month price targets for Medical Properties Trust, the average price target is $5.61. The highest price target for MPW is $10.00, while the lowest price target for MPW is $4.00. The average price target represents a forecasted upside of 9.86% from the current price of $5.11.

TypeCurrent Forecast
7/25/23 to 7/24/24
1 Month Ago
6/25/23 to 6/24/24
3 Months Ago
4/26/23 to 4/25/24
1 Year Ago
7/25/22 to 7/25/23
Consensus Rating
Reduce
Reduce
Reduce
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
1 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
8 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
Sell
4 Sell rating(s)
4 Sell rating(s)
4 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.61$5.80$5.75$13.08
Forecasted Upside9.86% Upside8.94% Upside13.86% Upside30.76% Upside
Get Medical Properties Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MPW and its competitors with MarketBeat's FREE daily newsletter.

MPW Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MPW Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medical Properties Trust Stock vs. The Competition

TypeMedical Properties TrustFinance CompaniesS&P 500
Consensus Rating Score
1.77
2.45
2.51
Consensus RatingReduceHoldModerate Buy
Predicted Upside9.86% Upside37.93% Upside10.61% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/2/2024BNP Paribas
3 of 5 stars
N. Crossett
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$6.00 ➝ $4.00-2.32%
5/30/2024Truist Financial
1 of 5 stars
 Boost TargetHold ➝ Hold$4.50 ➝ $5.00-0.60%
5/14/2024Royal Bank of Canada
4 of 5 stars
 Reiterated RatingOutperform ➝ Sector Perform$5.00-10.23%
4/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold$2.00 ➝ $5.00+4.17%
4/10/2024Colliers Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$10.00 ➝ $4.25-0.47%
1/5/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Sector Weight
1/3/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$9.00 ➝ $7.00+38.34%
11/29/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$8.00 ➝ $5.00+3.31%
11/10/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$12.00 ➝ $4.50-3.12%
10/16/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeEqual Weight ➝ Underweight$7.00 ➝ $4.00-19.35%
8/22/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$12.00 ➝ $10.00+42.65%
8/11/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeStrong-Buy ➝ Underperform
8/11/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underperform$9.00 ➝ $8.00-1.60%
3/7/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$11.00+9.34%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:16 PM ET.

MPW Forecast - Frequently Asked Questions

What is Medical Properties Trust's forecast for 2024?

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Medical Properties Trust is $5.61, with a high forecast of $10.00 and a low forecast of $4.00.

Should I buy or sell Medical Properties Trust stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last twelve months. There are currently 4 sell ratings, 8 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" MPW shares.

Does Medical Properties Trust's stock price have much upside?

According to analysts, Medical Properties Trust's stock has a predicted upside of 5.72% based on their 12-month stock forecasts.

Has Medical Properties Trust been downgraded by Wall Street analysts recently?

Over the previous 90 days, Medical Properties Trust's stock had 1 downgrade by analysts.

What analysts cover Medical Properties Trust?

Medical Properties Trust has been rated by research analysts at BNP Paribas, Royal Bank of Canada, and Truist Financial in the past 90 days.

Do Wall Street analysts like Medical Properties Trust more than its competitors?

Analysts like Medical Properties Trust less than other "finance" companies. The consensus rating for Medical Properties Trust is Reduce while the average consensus rating for "finance" companies is Hold. Learn more on how MPW compares to other companies.


This page (NYSE:MPW) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners